|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.120 CAD | +8.27% |
|
+24.35% | -30.12% |
| Capitalization | 220.99Cr 191.18Cr 179.38Cr 162.57Cr 300.12Cr 19TCr 339.46Cr 2.1TCr 815.83Cr 8.71TCr 829.49Cr 811.59Cr 32TCr | P/E ratio 2025 * |
11.3x | P/E ratio 2026 * | 4.94x |
|---|---|---|---|---|---|
| Enterprise value | 2.14TCr 1.85TCr 1.74TCr 1.57TCr 2.9TCr 1,84100Cr 3.28TCr 20TCr 7.89TCr 84TCr 8.02TCr 7.85TCr 3,07800Cr | EV / Sales 2025 * |
2.14x | EV / Sales 2026 * | 1.92x |
| Free-Float |
88.99% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Bausch Health Companies Inc.
More recommendations
More press releases
More news
| 1 day | +8.27% | ||
| 1 week | +24.35% | ||
| Current month | +30.55% | ||
| 1 month | +26.09% | ||
| 3 months | -20.93% | ||
| 6 months | -26.78% | ||
| Current year | -30.12% |
| 1 week | 6.56 |  | 8.2 |
| 1 month | 6.06 | | 8.2 |
| Current year | 5.91 | | 11.93 |
| 1 year | 5.45 | | 13.74 |
| 3 years | 5.1 | | 15.43 |
| 5 years | 5.1 | | 43.97 |
| 10 years | 5.1 | | 347.84 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 62 | 10/05/2022 |
| Director of Finance/CFO | 59 | 19/08/2024 | |
| Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Power
CHM | Chairman | 68 | 10/05/2022 |
Thomas Appio
BRD | Director/Board Member | 62 | 10/05/2022 |
Amy Wechsler
BRD | Director/Board Member | 55 | 14/06/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.27% | +24.35% | - | - | 220.99Cr | ||
| +0.90% | +6.43% | -6.73% | +179.65% | 74TCr | ||
| +0.28% | +1.34% | +7.94% | -7.58% | 38TCr | ||
| -0.70% | +0.66% | +13.34% | +38.37% | 34TCr | ||
| -1.06% | +0.56% | +8.93% | -12.36% | 27TCr | ||
| -0.93% | +0.08% | +2.26% | +19.86% | 23TCr | ||
| -0.40% | +1.89% | -12.18% | +11.47% | 23TCr | ||
| -0.13% | +3.47% | -36.89% | -3.45% | 21TCr | ||
| -0.70% | +1.68% | -1.14% | +25.32% | 16TCr | ||
| -1.21% | +5.10% | -10.86% | -49.41% | 14TCr | ||
| Average | +0.43% | +2.36% | -3.93% | +22.43% | 29.86TCr | |
| Weighted average by Cap. | -0.13% | +2.89% | -2.46% | +53.09% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1TCr 866.02Cr 812.58Cr 736.4Cr 1.36TCr 86TCr 1.54TCr 9.5TCr 3.7TCr 39TCr 3.76TCr 3.68TCr 1,44100Cr | 1.03TCr 890.46Cr 835.51Cr 757.18Cr 1.4TCr 89TCr 1.58TCr 9.77TCr 3.8TCr 41TCr 3.86TCr 3.78TCr 1,48200Cr |
| Net income | 26Cr 22Cr 21Cr 19Cr 35Cr 2.21TCr 39Cr 243.66Cr 95Cr 1.01TCr 96Cr 94Cr 3.7TCr | 47Cr 41Cr 38Cr 35Cr 64Cr 4.08TCr 73Cr 449.08Cr 174.74Cr 1.87TCr 177.66Cr 173.83Cr 6.82TCr |
| Net Debt | 1.92TCr 1.66TCr 1.56TCr 1.41TCr 2.6TCr 1,65000Cr 2.94TCr 18TCr 7.08TCr 76TCr 7.19TCr 7.04TCr 2,76000Cr | 1.75TCr 1.52TCr 1.42TCr 1.29TCr 2.38TCr 1,50900Cr 2.69TCr 17TCr 6.47TCr 69TCr 6.58TCr 6.44TCr 2,52400Cr |
More financial data
* Estimated data
Employees
20,700
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/25/13 | 8.120 $ | +8.27% | 11,04,774 |
| 12/25/12 | 7.500 $ | +3.02% | 4,93,051 |
| 11/25/11 | 7.280 $ | +4.75% | 5,28,265 |
| 10/25/10 | 6.950 $ | +4.35% | 3,89,169 |
| 09/25/09 | 6.660 $ | +1.99% | 3,68,665 |
Delayed Quote Toronto S.E., June 14, 2025 at 01:30 am IST
More quotes
Sell
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
5.980USD
Average target price
7.083USD
Spread / Average Target
+18.45%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- BHC Stock
- BHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition